In the model, the transmigration of immune cells into the tumor and the killing potential of T cells, which were assumed to be affected by vascular normalization, were transiently varied from the control to the normalized state, either following anti-VEGF antibody treatment or when CAR-T cell density exceeded the normalization threshold. The gene discussed is VEGFA; the disease is neoplasm.